Wren Calloway
Molecular biology PhD turned science journalist covering gene editing, synthetic biology, and the biotech industry. Has written about CRISPR since 2014 and watched the field slowly climb out of the valley of hype.
1 article published
Molecular biology PhD turned science journalist covering gene editing, synthetic biology, and the biotech industry. Has written about CRISPR since 2014 and watched the field slowly climb out of the valley of hype.
1 article published